Potent, stereoselective, and brain region selective modulation of second messengers in the rat brain by (+)LY354740, a novel group II metabotropic glutamate receptor agonist

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 358, Issue 2, 1998, Pages 175-180

  Schoepp, Darryle D ^a   Johnson, Bryan G ^a   Wright, Rebecca A ^a   Salhoff, Craig R ^a   Monn, James A ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

CAMP; Hippocampus; LY354740; Metabotropic glutamate receptors; Phosphoinositide hydrolysis

Indexed keywords

CYCLIC AMP; EGLUMETAD; FORSKOLIN; GLUTAMATE RECEPTOR; GLUTAMATE RECEPTOR ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; BRAIN CORTEX; CEREBELLUM; CONTROLLED STUDY; DRUG SELECTIVITY; HIPPOCAMPUS; NONHUMAN; RAT; SECOND MESSENGER; SIGNAL TRANSDUCTION; STEREOCHEMISTRY;

EID: 0031683115     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00005240     Document Type: Article

References (34)

1. Breakwell NA, Huang L, Rowan MJ, Anwyl R (1997) DCG-IV inhibits synaptic transmission by activation of NMDA receptors in area CAI of rat hippocampus. Eur J Pharmacol 322:173-178
2. Cartmell J, Schaffhauser H, Wichmann J, Mutel V (1997) mGluR-evoked augmentation of receptor-mediated cyclic AMP formation in neonatal and adult rat striatum. Br J Pharmacol 121:1263-1268
3. Desai MA, Burnett JP, Mayne N, Schoepp DD (1995) Cloning and expression of a human metabotropic glutamate receptor 1a: enhanced coupling on co-transfection with a glutamate transporter. Mol Pharmacol 48:648-657
4. 1H]-L-2-amino-4-phosphonobutyrate labels a metabotropic glutamate receptor, mGluR4a. Br J Pharmacol 116:3279-3287
5. Genazzani AA, L'Episcopo MR, Casabona G, Shinozaki H, Nicoletti F (1994) (2S.1′ R.2′ R.3′ R)-2-(2.3-dicarboxycyclopropyl)glycine positively modulates metabotropic glutamate receptors coupled to polyphosphoinositide hydrolysis in rat hippocampal slices. Brain Res 659:10-16
6. 3H]DOPA in various regions of the brain. J Neurochem 13:655-669
7. Hayashi Y, Momiyama A, Takahashi T, Ohishi H, Ogawa-Meguro R, Shigemoto R, Mizuno N, Nakanishi S (1993) Role of metabotropic glutamate receptor in synaptic modulation in the accessory olfactory bulb. Nature 366:681-690
8. Helton DR, Tizzano JP, Monn JA, Schoepp DD, Kallman MJ (1997) LY354740: a potent, orally active, highly selective metabotropic glutamate receptor agonist which ameliorates symptoms of nicotine withdrawal. Neuropharmacology 36:1511-1516
9. Helton DR, Tizzano JP, Monn JA, Schoepp DD, Kallman MJ (1998a) Anxiolytic and side-effect profile of LY354740: a potent, highly selective, orally active agonist for Group II metabotropic glutamate receptors. J Pharmacol Exp Ther 284:651-660
10. Helton DR, Schoepp DD, Monn JA, Tizzano JP, Kallman MJ (1998b) A role for metabotropic glutamate receptors in drug withdrawal states. In: Moroni F, Nicoletti F, Pellegrini-Giampietro DE (eds) Metabotropic glutamate receptors and brain function. Portland Press. London, (in press)
11. Knopfel T. Gasparini F (1996) Metabotropic glutamate receptors: potential drug targets. Drug Dev Today 1:103-107
12. Layne E (1957) Spectrophotometric and turbidimetric methods for measuring proteins. Methods Enzymol 3:447-454
13. Maslanski JA, Busa WB (1990) A sensitive and specific mass assay for myo-inositol and inositol phosphates. In: Irvine RF (ed) Methods in inositide research Raven Press, New York, pp 113-126
14. Monn JA, Valli MJ, Massey SM, Wright RA, Salhoff CR, Johnson BG, Howe T, Alt CA, Rhodes GA, Robey RL, Griffey KR, Tizzano JP, Kallman MJ, Helton DR, Schoepp DD (1997) Design, synthesis and pharmacological characterization of (+)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylate: a potent, selective, systemically active Group 2 metabotropic glutamate receptor agonist possessing anticonvulsant and anxiolytic properties. J Med Chem 40:528-537
15. Nakanishi S (1992) Molecular diversity of glutamate receptors and implications for brain function. Science 258:597-603
16. Neki A, Ohishi H, Kaneko T, Shigemoto R, Nakanishi S, Mizuno N (1996) Pre- and postsynaptic localization of a metabotropic glutamate receptor, mGluR2, in the rat brain: an immunohistochemical study with a monoclonal antibody. Neurosci Lett 202:197-200
17. Ohishi H, Shigemoto R, Nakanishi S, Mizuno N (1993a) Distribution of the messenger RNA for a metabotropic glutamate receptor mGluR2 in the central nervous system of the rat. Neuroscience 53: 1009-1018
18. Ohishi H, Shigemoto R, Nakanishi S, MiZuno N (1993b) Distribution for the mRNA for a metabotropic glutamate receptor (mGluR3) in the rat brain: an in situ hybridization study. J Comp Neurol 335:252-266
19. Petralia RS, Wang Y-X, Niedzielski AS, Wenthold RJ (1996) The metabotropic glutamate receptors. MGluR2 and mGluR3, show unique postsynaptic, presynaptic and glial localizations. Neuroscience 71:949-976
20. Pin J-P, Duvoisin R (1995) The metabotropic glutamate receptors: structure and functions. Neuropharmacology 34:1-26
21. Schaffhauser H, Cartmell J, Jakob-Rotne R, Mutel V (1997) Pharmacological characterization of metabotropic glutamate receptors linked to the inhibition of adenylate cyclase activity in rat striatal slices. Neuropharmacology 36:933-940
22. Schoepp DD, Conn PJ (1993) Metabotropic glutamate receptors in brain function and pathology. Trends Pharmacol Sci 14:13-20
23. Schoepp DD, Johnson BG (1988) Selective inhibition of excitatory amino acid-stimulated phosphoinositide hydrolysis in the rat hippocampus by activation of protein kinase C. Biochem Pharmacol 37:4299-4305
24. Schoepp DD, Johnson BG, Monn JA (1992) Inhibition of cyclic AMP formation by a selective metabotropic glutamate receptor agonist. J Neurochem 58:1184-1186
25. Schoepp DD, Goldsworthy J, Johnson BG, Salhoff CR, Baker SR (1994) 3,5-Dihydroxyphenylglycine is a highly selective agonist for phosphoinositide-linked metabotropic glutamate receptors in the rat hippocampus. J Neurochem 63:769-772
26. Schoepp DD, Johnson BG, Salhoff CR, Valli MJ, Desai MA, Burnett JP, Mayne NG, Monn JA (1995) Selective inhibition of forskolin-stimulated cyclic AMP formation in rat hippocampus by a novel mGluR agonist, 2R,4R-4-aminopyrrolidine-2,4-dicarboxylate. Neuropharmacology 34:843-850
27. Schoepp DD, Salhoff CR, Wright RA, Johnson BG, JP Burnett, NG Mayne, Belagaje R, Wu S, Monn JA (1996) The novel metabotropic glutamate receptor agonist 2R,4R-APDC potentiates stimulation of phosphoinositide hydrolysis in the rat hippocampus by 3,5-dihydroxyphenylglycine: evidence for a synergistic interaction between Group 1 and Group 2 receptors. Neuropharmacology 35:1661-1672
28. Schoepp DD, Johnson BG, Wright RA, Salhoff CR, Mayne NG, Wu S, Cockerham SL, Burnett JP, Belegaje R, Bleakman D, Monn JA (1997) LY354740 is a potent and highly selective Group II metabotropic glutamate receptor agonist in cells expressing human glutamate receptors. Neuropharmacology 36:1-11
29. Thomsen C, Boel E, Suzdak PD (1994) Actions of phenylglycine analogs at subtypes of the metabotropic glutamate receptor family. Eur J Pharmacol - Mol Pharmacol Sect 267:77-84
30. Wilsch VW, Pidoplichko VI, Opitz T, Shinozaki H, Reymann KG (1994) Metabotropic glutamate receptor agonist DCG-IV as NMDA receptor agonist in immature rat hippocampal neurons. Eur J Pharmacol 262:287-291
31. Winder DG, Conn PJ (1995) Metabotropic glutamate receptor (mGluR)-mediated potentiation of cyclic AMP responses does not require phosphoinositide hydrolysis: mediation by a Group II-like mGluR. J Neurochem 64:592-599
32. Winder DG, Ritch PS, Gereau RW, Conn PJ (1996) Novel glial-neuronal signaling by coactivation of metabotropic glutamate and β-adrenergic receptors in rat hippocampus. J Physiol 494:743-755
33. Wright RA, Schoepp DD (1996) Differentiation of Group 2 and Group 3 metabotropic glutamate receptor cAMP responses in the rat hippocampus. Eur J Pharmacol 297:275-282
34. Wu S, Wright RA, Rockey PK, Burgett SG, Arnold PR, Johnson BG, Schoepp DD, Belagaje R (1998) Group III human metabotropic glutamate receptors 4, 7, and 8: molecular cloning, functional expression, and comparison of pharmacological properties in RGT cells. Mol Brain Res 53:88-97